Humana Inc. · NYSE:HUM
Humana — Q4 2020 Earnings Presentation
5 slides from Humana's earnings presentation, Feb 3, 2021
Slide 1: Cautionary Statement
0 Cautionary Statement This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, Securities and Exchange Commission (SEC) filings, and in oral statements made by or with the a
Slide 2: Non-GAAP Financial Measures
1 Non-GAAP Financial Measures This slide presentation includes financial measures which are not in accordance with Generally Accepted Accounting Principles (GAAP). Humana has included these non-GAAP (Adjusted) financial measures since management believes these measures, when presented in conjunction
Slide 3: Diluted EPS – 2020 Adjusted to 2021E Adjusted
2 Diluted Earnings per Common Share (EPS) – 2020 Adjusted to 2021E Adjusted Reset to Baseline primarily net COVID-19 impact ($0.25) Retail $1.21 $0.05 Group and Specialty Corporate and Other $0.02 $21.50 EPS $18.75 EPS Healthcare Services $1.72 $18.50 EPS 2 2020 Adjusted 1. Amount represents the yea
Slide 4: 2021 Medicare Advantage COVID Headwinds and Tailwinds
Low (1) High (1) Headwinds: Medicare Risk Adjustment (MRA) ($700) ($1,000) COVID Testing and Treatment(2) ($525) ($925) Medicare Physician Fee Schedule Increase(3) ($175) ($200) Tailwinds: Depressed Non-COVID Utilization $1,320 $2,035 Sequestration Relief (4) (5) $80 $90 Net Estimated 2021 Pre-Tax M
Slide 5: Reconciliations of GAAP to non-GAAP financial measures
3 Reconciliations of GAAP to non-GAAP financial measures Diluted earnings per common share (EPS) FY 2020 FY 2021E Generally Accepted Accounting Principles (GAAP) $25.31 $20.82 to $21.32 Adjustments (described below) (6.56) ~$0.43 Adjusted (non-GAAP) $18.75 $21.25 to $21.75 FY 2020 Adjusted results e